Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies
GlyToucan Accession Number: G09614AM
Peak | Intensity |
---|---|
204.2 | 1414.0 |
305.1 | 760.0 |
323.1 | 4055.0 |
408.3 | 911.0 |
412.9 | 411.0 |
434.3 | 753.0 |
455.8 | 185.0 |
484.3 | 309.0 |
485.2 | 1957.0 |
485.4 | 1039.0 |
486.2 | 306.0 |
498.1 | 1145.0 |
502.7 | 907.0 |
503.2 | 2906.0 |
515.1 | 3864.0 |
515.7 | 815.0 |
528.1 | 1355.0 |
535.7 | 8949.0 |
536.3 | 2888.0 |
536.8 | 4048.0 |
546.3 | 173.0 |
551.6 | 725.0 |
575.2 | 3183.0 |
576.3 | 568.0 |
587.7 | 834.0 |
588.3 | 851.0 |
595.8 | 840.0 |
596.4 | 1387.0 |
605.2 | 439.0 |
612.2 | 1388.0 |
616.8 | 7867.0 |
617.2 | 8059.0 |
617.7 | 3539.0 |
618.3 | 2078.0 |
618.8 | 1714.0 |
629.3 | 2040.0 |
630.3 | 1020.0 |
647.3 | 2179.0 |
665.3 | 566.0 |
668.2 | 1773.0 |
678.3 | 1544.0 |
711.3 | 1133.0 |
792.0 | 611.0 |
833.1 | 723.0 |
869.4 | 2514.0 |
870.3 | 719.0 |
876.6 | 664.0 |
892.4 | 126.0 |
911.3 | 2522.0 |
912.5 | 1942.0 |
989.5 | 707.0 |
1008.5 | 1166.0 |
1012.3 | 1505.0 |
1031.3 | 3139.0 |
1031.5 | 4056.0 |
1032.3 | 2025.0 |
1032.5 | 1715.0 |
1033.3 | 455.0 |
1043.5 | 965.0 |
1072.2 | 1482.0 |
1072.5 | 577.0 |
1073.1 | 2384.0 |
1092.4 | 505.0 |
1115.5 | 783.0 |
1132.4 | 794.0 |
1174.6 | 2324.0 |
1175.5 | 169.0 |
1336.6 | 439.0 |